Following much opposition from drugmakers, Germany has scrapped its plan to install a program that would have reduced the price of branded pharmaceuticals in a variable structure,
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
Germany’s new healthcare reform initiative has already led two global drugmakers to slice their planned investments in the…
Eli Lilly and Boehringer Ingelheim are cutting back on planned investments in Germany in response to a new government healthcare…
In the U.S., many top brand-name drugs continue to get more expensive with age, while the same medicines often get cheaper in…
Even as a new drug pricing specter rears its head in President Donald Trump’s “Most Favored Nation” policies, drugmakers continue…
Backlash is brewing against a sweeping overhaul of Germany’s health insurance system as Eli Lilly and Boehringer Ingelheim slash…
With questions already swirling about the actual affordability impact of t | With questions already swirling about the actual…
